Fetal programming of children's obesity risk

Psychoneuroendocrinology

Volumn 53, Issue , 2015, Pages 29-39

  Stout, Stephanie A ^a   Espel, Emma V ^a   Sandman, Curt A ^b   Glynn, Laura M ^c   Davis, Elysia Poggi ^a,b  

^a UNIVERSITY OF DENVER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHAPMAN UNIVERSITY   (United States)

Author keywords

BMI; CRH; Early childhood; Fetal programming; Obesity; Prenatal

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; ARTICLE; BIOLOGICAL FUNCTIONS; BIRTH WEIGHT; BODY MASS; BODY SIZE; CATCH UP GROWTH; CHILD; CHILDHOOD OBESITY; DISEASE ASSOCIATION; FEMALE; FETAL PROGRAMMING; FETUS; GESTATIONAL AGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; LONGITUDINAL STUDY; MALE; NEWBORN; NORMAL HUMAN; PLACENTA; PRENATAL EXPOSURE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THIRD TRIMESTER PREGNANCY; FETUS DEVELOPMENT; METABOLISM; OBESITY; PREGNANCY; PRESCHOOL CHILD; YOUNG ADULT;

ADULT; BODY MASS INDEX; CHILD, PRESCHOOL; CORTICOTROPIN-RELEASING HORMONE; FEMALE; FETAL DEVELOPMENT; HUMANS; HYDROCORTISONE; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; OBESITY; PLACENTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84922830601     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.12.009     Document Type: Article

References (57)

1. ACOG ACOG practice bulletin No. 101. Obstet. Gynecol. 2009, 113:451-461.
2. Barker D.J. In utero programming of chronic disease. Clin. Sci. 1998, 95:115-128.
3. Calkins K., Devaskar S.U. Fetal origins of adult disease. Curr. Probl. Pediatr. Adolesc. Health Care 2011, 41:158-176. 10.1016/j.cppeds.2011.01.001.
4. Cheng Y., Nicholson R.C., King B., Chan E., Fitter J.T., Smith R. Glucocorticoid stimulation of corticotropin-releasing hormone gene expression requires a cyclic adenosine primary placental cytotrophoblast cells. J. Clin. Endocrinol. Metab. 2000, 85:1937-1945.
5. Choquet H., Meyre D. Genetics of obesity: what have we learned?. Curr. Genomics 2011, 12:169-179. 10.2174/138920211795677895.
6. Cianfarani S., Germani D., Branca F. Low birth weight and adult insulin resistance: the catch-up growth hypothesis. Arch. Dis. Child. Fetal Neonatal 1999, 81:F71-F73.
7. Cole T.J., Faith M.S., Pietrobelli A., Heo M. What is the best measure of adiposity change in growing children: BMI, BMI %. BMI z-score or BMI centile?. Eur. J. Clin. Nutr. 2005, 59:419-425. 10.1038/sj.ejcn.1602090.
8. Cole T.J., Green P.J. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat. Med. 1992, 11:1305-1319.
9. Daniels S.R., Arnett D.K., Eckel R.H., Gidding S.S., Hayman L.L., Kumanyika S., Robinson T.N., Scott B.J., St Jeor S., Williams C.L. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005, 111:1999-2012. 10.1161/01.CIR.0000161369.71722.10.
10. Davis E.P., Glynn L.M., Dunkel Schetter C., Hobel C., Chicz-Demet A., Sandman C.A. Corticotropin-releasing hormone during pregnancy is associated with infant temperament. Dev. Neurosci. 2005, 27:299-305. 10.1159/000086709.
11. Davis E.P., Sandman C.A. The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Dev. 2010, 81:131-148. 10.1111/j. 1467-8624.2009.01385.x.
12. Davis E.P., Waffarn F., Uy C., Hobel C.J., Glynn L.M., Sandman C.A. Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation. J. Perinatol. 2009, 29:731-737. 10.1038/jp.2009.85.
13. Drapeau V., Therrien F., Richard D., Tremblay A. Is visceral obesity a physiological adaptation to stress?. Panminerva Med. 2003, 45:189-195.
14. Dulloo A.G., Jacquet J., Seydoux J., Montani J.-P. The thrifty catch-up fat phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int. J. Obes. 2006, 30(Suppl. 4):S23-S35. 10.1038/sj.ijo.0803516.
15. Duthie L., Reynolds R.M. Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: influences on maternal and fetal outcomes. Neuroendocrinology 2013, 10.1159/000354702.
16. Ellman L.M., Schetter C.D., Hobel C.J., Chicz-Demet A., Glynn L.M., Sandman C.A. Timing of fetal exposure to stress hormones: effects on newborn physical and neuromuscular maturation. Dev. Psychobiol. 2008, 50:232-241. 10.1002/dev.20293.
17. Entringer S. Impact of stress and stress physiology during pregnancy on child metabolic function and obesity risk. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16:320-327. 10.1097/MCO.0b013e32835e8d80.
18. Eriksson J.G., Osmond C., Kajantie E., Forsen T.J., Barker D.J. Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia 2006, 49:2853-2858. 10.1007/s00125-006-0459-1.
19. Fasting M.H., Oken E., Mantzoros C.S., Rich-Edwards J.W., Majzoub J.A., Kleinman K., Rifas-Shiman S.L., Vik T., Gillman M.W. Maternal levels of corticotropin-releasing hormone during pregnancy in relation to adiponectin and leptin in early childhood. J. Clin. Endocrinol. Metab. 2009, 94:1409-1415. 10.1210/jc. 2008-1424.
20. Frayn K., Arner P., Yki-Jarvinen H. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays Biochem. 2006, 42:89-103.
21. Gangestad S.W., Caldwell Hooper A.E., Eaton M.A. On the function of placental corticotropin-releasing hormone: a role in maternal-fetal conflicts over blood glucose concentrations. Biol. Rev. Camb. Philos. Soc. 2012, 87:856-873. 10.1111/j.1469-185X.2012.00226.x.
22. Gillman M., Rich-Edwards J., Huh S., Majzoub J.A., Oken E., Taveras E., Rifas-Shiman S.L. Maternal corticotropin-releasing hormone levels during pregnancy and offspring adiposity. Obesity 2006, 14:1647-1653.
23. Gitau R., Fisk N., Glover V. Human fetal and maternal corticotrophin releasing hormone responses to acute stress. Arch. Dis. Child. Fetal Neonatal Ed. 2004, 89:F29-F32.
24. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 2008, 359:61-73. 10.1056/NEJMra0708473.
25. Goland R.S., Wardlaw S.L., Blum M., Tropper P.J., Stark R.I. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am. J. Obstet. Gynecol. 1988, 159:884-890.
26. Gray D.S., Fujioka K. Use of relative weight and body mass index for the determination of adiposity. J. Clin. Epidemiol. 1991, 44:545-550.
27. Hohwü L., Li J., Olsen J., Sørensen T.I.A., Obel C. Severe maternal stress exposure due to bereavement before, during and after pregnancy and risk of overweight and obesity in young adult men: a Danish National Cohort Study. PLOS ONE 2014, 9:e97490. 10.1371/journal.pone.0097490.
28. Khan A.A., Rodriguez A., Kaakinen M., Pouta A., Hartikainen A.-L., Jarvelin M.-R. Does in utero exposure to synthetic glucocorticoids influence birth weight, head circumference and birth length? A systematic review of current evidence in humans. Paediatr. Perinat. Epidemiol. 2011, 25:20-36. 10.1111/j. 1365-3016.2010.01147.x.
29. Li J., Olsen J., Vestergaard M., Obel C., Baker J.L., Sørensen T.I.A. Prenatal stress exposure related to maternal bereavement and risk of childhood overweight. PLoS ONE 2010, 5:e11896. 10.1371/journal.pone.0011896.
30. Linton E., Perkins A., Hagan P., Poole S., Bristow A.F., Tilders F., Corder R., Wolfe C.D.A. Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding: implications for direct CRH immunoassay. J. Endocrinol. 1995, 146:45-53.
31. Lowry P.J. Corticotropin-releasing factor and its binding protein in human plasma. Ciba Found. Symp. 1993, 172:108-128.
32. Mastorakos G., Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann. N. Y. Acad. Sci. 2003, 997:136-149. 10.1196/annals.1290.016.
33. McLachlan G., Peel D. Finite Mixture Models 2000, Wiley, New York. 10.1002/0471721182.ch1.
34. McLean M., Bisits A., Davies J., Woods R., Lowry P., Smith R. A placental clock controlling the length of human pregnancy. Nat. Med. 1995, 1:460-463. 10.1038/nm0595-460.
35. Mei Z., Grummer-Strawn L.M., Thompson D., Dietz W.H. Shifts in percentiles of growth during early childhood: analysis of longitudinal data from the California Child Health and Development Study. Pediatrics 2004, 113:e617-e627.
36. Muthén L.K., Muthén B.O. MPlus: Statistical Analysis with Latent Variables. User's Guide (Version 7) 2012.
37. Nagin D.S. Group-Based Modeling of Development 2005, Harvard University Press, London, England.
38. Nobili V., Alisi A., Panera N., Agostoni C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Pediatr. Endocrinol. Rev. 2008, 6:241-247.
39. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. J. Am. Med. Assoc. 2012, 307:483-490. 10.1001/jama.2012.40.
40. Ong K.K., Loos R.J.F. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta. Paediatr. 2006, 95:904-908. 10.1080/08035250600719754.
41. Ong K.K., Ahmed M.L., Emmett P.M., Preece M.A., Dunger D.B. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 2000, 320:967-971. 10.1136/bmj.320.7240.967.
42. Petraglia F. Neuroendocrinology of the human placenta. Front. Neuroendocrinol. 1990, 11:6-37.
43. Petraglia F., Sawchenko P.E., Rivier J., Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987, 328:717-719.
44. Petraglia F., Sutton S., Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am. J. Obstet. Gynecol. 1989, 160:247-251.
45. Reynolds R.M., Walker B.R. Human insulin resistance: the role of glucocorticoids. Diabetes. Obes. Metab. 2003, 5:5-12.
46. Robinson B.G., Emanuel R.L., Frim D.M., Majzoub J.A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5244-5248.
47. Rodbard D., Munson P., De Lean A. Improved curve fitting, parallelism testing, characterization of sensitivity and specificity, validation, and optimization for radioligand assays. Radioimmunoassay and Related Procedures in Medicine 1973, 469-503. Vienna.
48. Sandman C.A., Davis E.P. Neurobehavioral risk is associated with gestational exposure to stress hormones. Expert Rev. Endocrinol. Metab. 2012, 7:445-459. 10.1586/eem.12.33.
49. Sandman C.A., Glynn L., Schetter C.D., Wadhwa P., Garite T., Chicz-DeMet A., Hobel C. Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock. Peptides 2006, 27:1457-1463. 10.1016/j.peptides.2005.10.002.
50. Schmid J., Ludwig B., Schally A.V., Steffen A., Ziegler C.G., Block N.L., Koutmani Y., Brendel M.D., Karalis K.P., Simeonovic C.J., Licinio J., Ehrhart-Bornstein M., Bornstein S.R. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11β-hydroxysteroid dehydrogenase. Proc. Natl. Acad. Sci. U. S. A. 2011, http://www.pnas.org/cgi/, 10.1073/pnas.1110965108.
51. Street M., Smerieri A., Petraroli A., Cesari S., Viani I., Garrubba M., Rossi M., Bernasconi S. Placental cortisol and cord serum IGFBP-2 concentrations are important determinants of postnatal weight gain. J. Biol. Regul. Homeost. Agents 2011, 26:21-31.
52. Wadhwa P.D., Garite T.J., Porto M., Glynn L., Chicz-DeMet A., Dunkel-Schetter C., Sandman C.A. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am. J. Obstet. Gynecol. 2004, 191:1063-1069. 10.1016/j.ajog.2004.06.070.
53. Wen X., Kleinman K., Gillman M.W., Rifas-Shiman S.L., Taveras E.M. Childhood body mass index trajectories: modeling, characterizing, pairwise correlations and socio-demographic predictors of trajectory characteristics. BMC Med. Res. Methodol. 2012, 12:38. 10.1186/1471-2288-12-38.
54. WHO Multicentre Growth Reference Study Group WHO Child Growth Standards: Length/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and development 2006, WHO Multicentre Growth Reference Study Group, Geneva.
55. Williams M.T., Hennessy M.B., Davis H.N. CRF administered to pregnant rats alters offspring behavior and morphology. Pharmacol. Biochem. Behav. 1995, 52:161-167.
56. Zadina J.E., Kastin A.J., Coy D.H., Adinoff B.A. Developmental, behavioral, and opiate receptor changes after prenatal or postnatal beta-endorphin, CRF, or Tyr-MIF-1. Psychoneuroendocrinology 1985, 10:367-383.
57. Ziyab A.H., Karmaus W., Kurukulaaratchy R.J., Zhang H., Arshad S.H. Developmental trajectories of body mass index from infancy to 18 years of age: prenatal determinants and health consequences. J. Epidemiol. Community Health 2014, 10.1136/jech-2014-203808.